Innovative take on Deep Brain Stimulation (DBS) provides precisely targeted treatment options for movement disorders.

Facing Parkinson's With a Smartphone App

Jun 23 2020

There are a handful of keys to every happy life: one in which we chart our path, stake out our priorities, meet and then overcome, challenges.

One of the most important of these keys is control. Imagine life without it. Without the ability to control what we do and how we choose to do it, we are rudderless, often powerless. Buffeted. At the mercy of the winds directing us.

Imagine not having the control to trust your hand to complete the signature you’ve made thousands of times; or even drinking from a cup. This is the increasing loss of control that comes with the onset of Parkinson’s disease or Essential Tremor – common, progressive neurological disorders that can cause hands/arms to shake.

These conditions can drain a person’s ability to command their own body, reducing independence and self-esteem at an alarming rate.

If you suffer from either, you are not alone. More than 10 million people worldwide battle Parkinson's,1 with 60,000 new diagnoses per year in the United States alone.2

Now imagine regaining some of that control.

Not with the pharmaceuticals that may have less and less impact on your condition over time, but with a life-changing device. Imagine an innovative method of reaching the inner recesses of your brain, where the ability to command your physical functions resides, waiting to be accessed.

This field of treatment is known as neuromodulation and the specific therapy is known as deep brain stimulation (DBS), a sophisticated means of potentially allowing the patient, in large part, to regain their autonomy.

DBS delivers mild electrical impulses to specific targets in the brain to stimulate the structures involved in motor control, while at the same time blocking electrical signals that cause involuntary movements.

While this initial technology was first approved in the United States in 2002 and has helped treat more than 40,000 patients in the meantime, there had been little progress made in the surrounding science.

That was, until the introduction of the innovative science at the forefront of a unique approach to this disease management: Abbott's Directional Lead technology

The Abbott Infinity Deep Brain Stimulation System advances the science of DBS by allowing new levels of control to battle the patient’s loss of the same.

The Abbott Infinity DBS System has segmented directional leads at the end of the fine, thin wire designed to steer mild electrical current toward the targeted structural areas in the brain, to improve symptom relief and limit side effects3.

What makes the Abbott Infinity system truly remarkable is that, by using a wireless app, the physician can adjust the electrical stimulation to best serve the patient. The resulting increase in the number of treatment options is amazing, now reaching into the billions.

This permits more tailored, nuanced therapies for each individual patient.

This highly-advanced new level of control can result, under the right circumstances, in significant physical improvements that can be seen almost immediately. In addition, the Abbott Infinity system has a sleek design for enhanced patient comfort and is -- thanks to additional advanced technology – one of the smallest devices of its kind on the market.

Imagine being able to return to the kind of life that you control with a nervous system that doesn't completely control you. Imagine having the control that can decrease your dependence on others, giving all involved more independence, more options.

Imagine a device that provides control over an extraordinary number of treatment settings to best meet your individual needs, and limit side-effects.

No matter the individual details, that best life is best lived by having as much control over it as possible. Imagine choosing your own path and priorities. Imagine life-changing technology that allows a return of that control.

Imagine...but with Abbott Infinity Deep Brain Stimulation System, you don’t have to imagine any longer.

It’s here.

See important safety information on DBS.

1. 10 million PD: Abdullah, Rashed, et al. "Parkinson's disease and age: the obvious but largely unexplored link." Experimental gerontology 68 (2015): 33-38.
2. 60000 PD: DeMaagd, George, and Ashok Philip. "Parkinson’s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis." Pharmacy and Therapeutics 40.8 (2015): 504.
3. Improving symptom relief: Vesper J, Mir P, Brodsky M, Verhagen L, Groppa S, Cheeran B, Karst E, Defresne F, Schnitzler A. "Directional versus conventional deep brain stimulation for Parkinson’s disease: 3-month results of a prospective, blinded-comparison, multicenter study." Oral presentation at: World Society Stereotactic and Functional Neurosurgery Congress; June 26, 2019; New York.



You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?


You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.

The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?